The Latest

• June 03, 2022

  By Charleston Lim

  Regeneron Shares Dip Amid $1.1 Billion Cancer Drug Deal

  Regeneron's shares dropped by 4.3% to 630.70 per share after it announced its $1.1 billion deal with Sanofi.

  

  Regeneron's shares dropped by 4.3% to 630.70 per share after it announced its $1.1 billion deal with Sanofi.
• October 09, 2020

  By Stacy Pantoja-Contreras

  Why Donald Trump Calls His COVID-19 Diagnosis A 'Blessing From God'

  Donald Trump posted a five-minute video on social media, wherein he refers to his diagnosis as a "blessing in disguise."

  

  Donald Trump posted a five-minute video on social media, wherein he refers to his diagnosis as a "blessing in disguise."